Premium
Genetic polymorphisms in CYP17 , CYP3A4 , CYP19A1 , SRD5A2 , IGF‐1 , and IGFBP‐3 and prostate cancer risk in African‐American men: The Flint Men's Health Study
Author(s) -
Sarma Aruna V.,
Dunn Rodney L.,
Lange Leslie A.,
Ray Anna,
Wang Yunfei,
Lange Ethan M.,
Cooney Kathleen A.
Publication year - 2007
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/pros.20696
Subject(s) - prostate cancer , medicine , african american , oncology , cyp3a4 , biology , gynecology , cancer , cytochrome p450 , ethnology , metabolism , history
BACKGROUND Association studies have examined the significance of several candidate genes based on biological pathways relevant to prostate carcinogenesis, including both the androgen and insulin‐like growth factor pathways. Clinical and epidemiologic evidence suggest that androgens, specifically testosterone and dihydrotestosterone (DHT) are important not only in normal prostate growth but in the pathogenesis of prostate cancer. Similarly, the insulin‐like growth factor‐1 (IGF‐1) signaling pathway regulates both cellular proliferation and apoptosis. Therefore, genes involved in the biosynthesis, activation, metabolism and degradation of androgens and the stimulation of mitogenic and antiapoptotic activities of prostate epithelial cells represent important candidates for affecting the development and progression of prostate cancer. METHODS Using resources from the Flint Men's Health Study, a population‐based case control study of African‐American men aged 40–79, we evaluated the associations between selected single‐nucleotide polymorphisms (SNPs) in the CYP17 , CYP3A4 , CYP19A1 , SDR5A2 , IGF1 , and IGFBP3 genes and prostate cancer diagnosis in 473 men (131 prostate cancer cases and 342 disease‐free controls). RESULTS We found a significant association between prostate cancer and selected CYP17 SNP genotypes, with the heterozygous genotype conferring decreased risk. Suggestive evidence for association between IGF1 SNPs and prostate cancer were also found. No significant associations were observed between SNPs in the other genes and prostate cancer. CONCLUSIONS These findings suggest that variation in or around CYP17 and/or IGF1 may be associated with prostate cancer development in the African‐American population. Additional studies are needed to determine whether these polymorphisms are indeed associated with prostate cancer risk in African Americans. Prostate 68: 296–305, 2008. © 2007 Wiley‐Liss, Inc.